The World Anti-Doping Agency added BPC-157 to its Prohibited List under category S0 (non-approved substances) in 2022
A simple, rapid, and accurate point-of-care test (POCT) made accessible to resource limited parts of the world with high prevalence of G6PD deficiency may help in early diagnosis and to curb severe hyperbilirubinemia with counseling and advice on taking the necessary steps for prompt intervention
Due to high demand, the product may sometimes be out of stock or have limited availability
Ann Pharmacother 48(11):14941501 Uccellatore A, Genovese S, Dicembrini I, Mannucci E, Ceriello A (2015) Comparison review of short-acting and long-acting glucagon-like peptide-1 receptor agonists
TB-500: Actin Sequestration Cellular Structure & Migration TB-500 functions primarily through its interaction with actin, a fundamental structural protein comprising up to 10% of total cellular proteins[3]